feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Flu Season Low, But New Virus Strain Emerges

Flu Season Low, But New Virus Strain Emerges

13 Dec

•

Summary

  • Flu activity is low nationwide, but high in four states.
  • A new variant of H3N2 flu strain differs from current shots.
  • RSV infections are increasing, but new vaccines offer protection.
Flu Season Low, But New Virus Strain Emerges

Flu season activity is currently low nationwide, with only Colorado, Louisiana, New Jersey, and New York reporting high levels. Severity indicators are within mild season boundaries, though a concerning new variant of the H3N2 flu strain has been identified, which differs from the current year's vaccine.

Respiratory Syncytial Virus (RSV) cases are trending upward, with infections increasing in the South and mid-Atlantic states. However, new vaccines for pregnant women and older adults, along with antibody injections for infants, are expected to provide protection.

COVID-19 activity is at a low point. Recent research shows that COVID-19 vaccines remain effective in preventing severe illness in children, although uptake for this season's vaccine remains low among both children and adults.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
trending

Park Medi World IPO Opens

trending

HCC rights issue opens

trending

Hindustan Zinc share price rallies

trending

Silver hits record high

trending

ICSI CS December exams admit

trending

Nephrocare IPO open today

trending

Ratcliffe's cuts boost Man United

trending

KOSPI rises; Dow hits record

trending

Disney, OpenAI partner on Sora

As of last week, flu activity was high in four states (Colorado, Louisiana, New Jersey, New York) and minimal or low in most others.
Yes, new RSV vaccines were licensed in 2023 for pregnant women and older people, and injections of laboratory-made antibodies are available for infants.
Recent CDC research shows COVID-19 vaccines are 76% effective against severe illness in children aged nine months to 4 years, and 56% effective in older children.

Read more news on

Healthside-arrow

You may also like

Winter Illnesses Rise: Get Vaccinated!

19 hours ago • 8 reads

article image

Flu Contagious: Know the Timeline

1 day ago • 4 reads

article image

Superflu Alert: US Faces Quadruple Virus Threat

10 Dec • 53 reads

article image

Cold, Flu, or COVID? Spot the Difference Fast

9 Dec • 23 reads

article image

Flu & RSV Surge: Last Chance for Christmas Vax

5 Dec • 56 reads

article image